Concepts (343)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Irritable Bowel Syndrome | 25 | 2024 | 453 | 9.940 |
Why?
|
Constipation | 35 | 2024 | 561 | 8.880 |
Why?
|
Fecal Incontinence | 10 | 2023 | 241 | 3.710 |
Why?
|
Gastrointestinal Diseases | 10 | 2024 | 1185 | 3.560 |
Why?
|
Gastrointestinal Transit | 9 | 2024 | 99 | 3.490 |
Why?
|
Laxatives | 8 | 2024 | 92 | 2.570 |
Why?
|
Defecation | 7 | 2023 | 190 | 2.360 |
Why?
|
Diarrhea | 11 | 2024 | 1317 | 1.660 |
Why?
|
Gastroenterology | 7 | 2024 | 571 | 1.660 |
Why?
|
Dyspepsia | 3 | 2023 | 116 | 1.640 |
Why?
|
Gastrointestinal Motility | 5 | 2022 | 234 | 1.460 |
Why?
|
Manometry | 14 | 2024 | 453 | 1.420 |
Why?
|
Anal Canal | 6 | 2023 | 372 | 1.330 |
Why?
|
Rectal Diseases | 4 | 2023 | 144 | 1.240 |
Why?
|
Dietary Fiber | 3 | 2023 | 759 | 1.050 |
Why?
|
Colonoscopy | 12 | 2024 | 1388 | 1.030 |
Why?
|
Gastroparesis | 3 | 2023 | 136 | 0.950 |
Why?
|
Nurses | 4 | 2023 | 2467 | 0.910 |
Why?
|
Colon | 5 | 2019 | 1787 | 0.900 |
Why?
|
Dyspareunia | 1 | 2024 | 48 | 0.900 |
Why?
|
Abdominal Pain | 4 | 2024 | 1063 | 0.880 |
Why?
|
Rectum | 4 | 2023 | 895 | 0.870 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2023 | 92 | 0.830 |
Why?
|
Nausea | 2 | 2022 | 677 | 0.830 |
Why?
|
Heartburn | 1 | 2022 | 67 | 0.820 |
Why?
|
Pelvic Floor | 4 | 2020 | 138 | 0.820 |
Why?
|
Anorexia | 1 | 2022 | 154 | 0.790 |
Why?
|
Metagenomics | 2 | 2024 | 457 | 0.780 |
Why?
|
Cecum | 1 | 2022 | 232 | 0.770 |
Why?
|
Angioedemas, Hereditary | 1 | 2022 | 91 | 0.760 |
Why?
|
Benzofurans | 1 | 2022 | 140 | 0.750 |
Why?
|
Lumbosacral Plexus | 1 | 2020 | 51 | 0.730 |
Why?
|
Search Engine | 1 | 2020 | 140 | 0.640 |
Why?
|
Critical Illness | 2 | 2022 | 2703 | 0.640 |
Why?
|
Tai Ji | 1 | 2022 | 287 | 0.630 |
Why?
|
Phenylalanine | 1 | 2020 | 365 | 0.620 |
Why?
|
Postmenopause | 2 | 2018 | 2509 | 0.620 |
Why?
|
Endoscopy, Digestive System | 1 | 2020 | 351 | 0.600 |
Why?
|
Humans | 117 | 2024 | 758406 | 0.590 |
Why?
|
Gastroesophageal Reflux | 5 | 2023 | 816 | 0.580 |
Why?
|
Cecostomy | 1 | 2017 | 10 | 0.570 |
Why?
|
Marijuana Smoking | 1 | 2020 | 258 | 0.570 |
Why?
|
Absenteeism | 1 | 2018 | 249 | 0.540 |
Why?
|
Healthcare Disparities | 2 | 2024 | 3364 | 0.540 |
Why?
|
Joint Instability | 1 | 2023 | 795 | 0.530 |
Why?
|
Eating | 9 | 2023 | 1536 | 0.510 |
Why?
|
Vomiting | 3 | 2024 | 651 | 0.510 |
Why?
|
Gastrointestinal Agents | 1 | 2020 | 508 | 0.490 |
Why?
|
Lung Transplantation | 2 | 2021 | 1305 | 0.490 |
Why?
|
Adult | 50 | 2024 | 219935 | 0.480 |
Why?
|
Colon, Sigmoid | 1 | 2015 | 124 | 0.480 |
Why?
|
Intestinal Diseases | 1 | 2019 | 505 | 0.470 |
Why?
|
Imidazoles | 1 | 2020 | 1179 | 0.450 |
Why?
|
Chronic Disease | 11 | 2024 | 9267 | 0.440 |
Why?
|
Female | 67 | 2024 | 390323 | 0.440 |
Why?
|
Sweden | 5 | 2024 | 1376 | 0.430 |
Why?
|
Middle Aged | 46 | 2024 | 219568 | 0.420 |
Why?
|
Anti-Bacterial Agents | 4 | 2024 | 7403 | 0.420 |
Why?
|
Colorectal Neoplasms | 6 | 2023 | 6852 | 0.410 |
Why?
|
Feeding Behavior | 2 | 2024 | 3184 | 0.410 |
Why?
|
Prevalence | 12 | 2024 | 15651 | 0.410 |
Why?
|
Analgesics | 1 | 2019 | 1064 | 0.400 |
Why?
|
Pain Measurement | 1 | 2022 | 3527 | 0.380 |
Why?
|
Comorbidity | 7 | 2024 | 10495 | 0.380 |
Why?
|
Male | 53 | 2024 | 358747 | 0.370 |
Why?
|
Income | 1 | 2019 | 1872 | 0.360 |
Why?
|
Patient Selection | 2 | 2020 | 4244 | 0.360 |
Why?
|
Social Class | 1 | 2019 | 1999 | 0.360 |
Why?
|
Estrogen Replacement Therapy | 1 | 2017 | 1206 | 0.350 |
Why?
|
Retrospective Studies | 28 | 2024 | 80168 | 0.340 |
Why?
|
Quality of Life | 12 | 2023 | 13285 | 0.340 |
Why?
|
Aged | 34 | 2024 | 168218 | 0.330 |
Why?
|
Case-Control Studies | 10 | 2024 | 22029 | 0.330 |
Why?
|
Ataxia | 2 | 2022 | 305 | 0.330 |
Why?
|
Severity of Illness Index | 9 | 2024 | 15785 | 0.330 |
Why?
|
Intestines | 1 | 2018 | 1906 | 0.330 |
Why?
|
Young Adult | 19 | 2024 | 58808 | 0.310 |
Why?
|
Risk Factors | 21 | 2024 | 73809 | 0.310 |
Why?
|
Colitis, Microscopic | 2 | 2019 | 72 | 0.300 |
Why?
|
Cohort Studies | 10 | 2024 | 41256 | 0.300 |
Why?
|
Anxiety Disorders | 1 | 2019 | 2714 | 0.300 |
Why?
|
Gastric Emptying | 2 | 2021 | 242 | 0.300 |
Why?
|
Internet | 1 | 2020 | 3082 | 0.300 |
Why?
|
Prospective Studies | 19 | 2024 | 54137 | 0.300 |
Why?
|
Diverticulum | 2 | 2020 | 137 | 0.300 |
Why?
|
Referral and Consultation | 1 | 2020 | 3586 | 0.290 |
Why?
|
Feces | 3 | 2024 | 1456 | 0.280 |
Why?
|
Colonic Polyps | 2 | 2023 | 551 | 0.270 |
Why?
|
Adenoma | 4 | 2023 | 2148 | 0.270 |
Why?
|
Sex Characteristics | 1 | 2016 | 2621 | 0.270 |
Why?
|
Esophageal Motility Disorders | 2 | 2020 | 48 | 0.260 |
Why?
|
Treatment Outcome | 13 | 2024 | 64378 | 0.260 |
Why?
|
Diet | 4 | 2023 | 8005 | 0.260 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 25956 | 0.260 |
Why?
|
Colonic Diseases | 2 | 2017 | 200 | 0.250 |
Why?
|
Radiopharmaceuticals | 1 | 2015 | 2634 | 0.250 |
Why?
|
Biofeedback, Psychology | 2 | 2023 | 116 | 0.240 |
Why?
|
Exercise | 2 | 2018 | 5788 | 0.240 |
Why?
|
Incidence | 9 | 2024 | 21272 | 0.240 |
Why?
|
Laparoscopy | 1 | 2017 | 2147 | 0.240 |
Why?
|
Biopsy | 4 | 2021 | 6768 | 0.240 |
Why?
|
Telemedicine | 1 | 2021 | 3018 | 0.230 |
Why?
|
Multiple Sclerosis | 1 | 2019 | 3204 | 0.230 |
Why?
|
Obesity | 2 | 2024 | 12870 | 0.220 |
Why?
|
Advanced Practice Nursing | 1 | 2023 | 17 | 0.220 |
Why?
|
Drug Costs | 2 | 2021 | 1178 | 0.210 |
Why?
|
Depression | 2 | 2024 | 8057 | 0.210 |
Why?
|
Body Mass Index | 3 | 2024 | 12876 | 0.210 |
Why?
|
Dilatation | 1 | 2024 | 307 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3076 | 0.210 |
Why?
|
Risk Assessment | 4 | 2020 | 23884 | 0.210 |
Why?
|
Metagenome | 2 | 2024 | 450 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3196 | 0.200 |
Why?
|
Bile Acids and Salts | 1 | 2024 | 383 | 0.200 |
Why?
|
Pandemics | 3 | 2023 | 8611 | 0.200 |
Why?
|
Length of Stay | 1 | 2015 | 6439 | 0.200 |
Why?
|
Depressive Disorder, Major | 1 | 2019 | 4745 | 0.190 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3175 | 0.190 |
Why?
|
Emergency Service, Hospital | 2 | 2018 | 7810 | 0.190 |
Why?
|
Adolescent | 15 | 2024 | 87892 | 0.190 |
Why?
|
Eosinophilic Esophagitis | 1 | 2024 | 192 | 0.180 |
Why?
|
Aged, 80 and over | 13 | 2024 | 58683 | 0.180 |
Why?
|
Adenoma, Villous | 1 | 2020 | 14 | 0.180 |
Why?
|
Fermentation | 1 | 2020 | 146 | 0.180 |
Why?
|
Sigmoidoscopy | 1 | 2020 | 151 | 0.180 |
Why?
|
Digestive System Diseases | 1 | 2021 | 151 | 0.170 |
Why?
|
Gross Domestic Product | 1 | 2020 | 78 | 0.170 |
Why?
|
Cholangitis, Sclerosing | 1 | 2021 | 177 | 0.170 |
Why?
|
Breath Tests | 1 | 2020 | 297 | 0.170 |
Why?
|
Helicobacter pylori | 1 | 2023 | 376 | 0.170 |
Why?
|
Helicobacter Infections | 1 | 2023 | 385 | 0.160 |
Why?
|
Adenomatous Polyps | 1 | 2020 | 108 | 0.160 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12440 | 0.160 |
Why?
|
Anxiety | 3 | 2024 | 4539 | 0.160 |
Why?
|
Masks | 1 | 2021 | 207 | 0.160 |
Why?
|
Radiography, Abdominal | 2 | 2019 | 532 | 0.160 |
Why?
|
Strongylida Infections | 1 | 2018 | 48 | 0.160 |
Why?
|
Neurotransmitter Agents | 1 | 2022 | 663 | 0.160 |
Why?
|
Personal Satisfaction | 1 | 2023 | 643 | 0.160 |
Why?
|
Legislation, Drug | 1 | 2020 | 214 | 0.150 |
Why?
|
Odds Ratio | 2 | 2021 | 9650 | 0.150 |
Why?
|
Physician Assistants | 1 | 2020 | 188 | 0.150 |
Why?
|
Diagnostic Techniques, Digestive System | 1 | 2018 | 46 | 0.150 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2021 | 346 | 0.150 |
Why?
|
Diverticulitis | 1 | 2021 | 182 | 0.150 |
Why?
|
Deglutition Disorders | 1 | 2024 | 625 | 0.150 |
Why?
|
Stomach | 1 | 2022 | 694 | 0.150 |
Why?
|
Tea | 1 | 2019 | 284 | 0.150 |
Why?
|
Intussusception | 1 | 2019 | 115 | 0.150 |
Why?
|
Professional Role | 1 | 2020 | 309 | 0.150 |
Why?
|
Nurse Practitioners | 1 | 2020 | 268 | 0.150 |
Why?
|
Dinoprostone | 1 | 2020 | 598 | 0.140 |
Why?
|
Postprandial Period | 1 | 2019 | 314 | 0.140 |
Why?
|
Carcinoma | 2 | 2020 | 2330 | 0.140 |
Why?
|
Urologic Surgical Procedures | 1 | 2020 | 309 | 0.140 |
Why?
|
Aspirin | 2 | 2020 | 3131 | 0.140 |
Why?
|
Bacteria | 2 | 2024 | 2197 | 0.140 |
Why?
|
Patient Preference | 2 | 2021 | 921 | 0.140 |
Why?
|
Food | 1 | 2021 | 771 | 0.140 |
Why?
|
Minority Groups | 1 | 2024 | 1206 | 0.130 |
Why?
|
Enema | 1 | 2017 | 141 | 0.130 |
Why?
|
Communication | 2 | 2020 | 3846 | 0.130 |
Why?
|
United States | 11 | 2021 | 72136 | 0.130 |
Why?
|
Feasibility Studies | 3 | 2022 | 5199 | 0.130 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 550 | 0.130 |
Why?
|
Bile Duct Neoplasms | 1 | 2021 | 602 | 0.130 |
Why?
|
Follow-Up Studies | 6 | 2021 | 39059 | 0.130 |
Why?
|
Consensus | 3 | 2020 | 3099 | 0.130 |
Why?
|
Celiac Disease | 1 | 2024 | 822 | 0.130 |
Why?
|
Pancreatitis | 1 | 2023 | 1098 | 0.130 |
Why?
|
Hospitalization | 1 | 2015 | 10652 | 0.130 |
Why?
|
Drug Substitution | 1 | 2018 | 288 | 0.130 |
Why?
|
Algorithms | 3 | 2021 | 13961 | 0.130 |
Why?
|
Urinary Incontinence | 1 | 2019 | 495 | 0.120 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 249 | 0.120 |
Why?
|
Contrast Media | 2 | 2019 | 5298 | 0.120 |
Why?
|
Intestinal Obstruction | 1 | 2019 | 433 | 0.120 |
Why?
|
Patient Care Planning | 1 | 2020 | 907 | 0.120 |
Why?
|
Enteral Nutrition | 1 | 2021 | 785 | 0.120 |
Why?
|
Pyloric Antrum | 1 | 2014 | 66 | 0.120 |
Why?
|
Vegetables | 1 | 2020 | 1195 | 0.120 |
Why?
|
Child | 9 | 2024 | 79818 | 0.120 |
Why?
|
Communicable Disease Control | 1 | 2021 | 842 | 0.120 |
Why?
|
Critical Pathways | 1 | 2018 | 473 | 0.120 |
Why?
|
Urology | 1 | 2020 | 423 | 0.120 |
Why?
|
Hirschsprung Disease | 1 | 2016 | 163 | 0.120 |
Why?
|
Postoperative Complications | 1 | 2017 | 15637 | 0.120 |
Why?
|
Societies, Medical | 3 | 2024 | 3891 | 0.120 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12096 | 0.120 |
Why?
|
Logistic Models | 2 | 2019 | 13276 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1780 | 0.110 |
Why?
|
Gynecology | 1 | 2020 | 528 | 0.110 |
Why?
|
Body Weight | 1 | 2024 | 4603 | 0.110 |
Why?
|
Prescription Drugs | 1 | 2021 | 626 | 0.110 |
Why?
|
Time Factors | 5 | 2019 | 39872 | 0.110 |
Why?
|
Digestive System Surgical Procedures | 1 | 2018 | 575 | 0.110 |
Why?
|
Outpatients | 1 | 2020 | 1591 | 0.100 |
Why?
|
Double-Blind Method | 3 | 2022 | 12262 | 0.100 |
Why?
|
Nutrition Surveys | 1 | 2019 | 1716 | 0.100 |
Why?
|
Attitude to Health | 1 | 2021 | 2026 | 0.100 |
Why?
|
Drug Resistance | 1 | 2018 | 1593 | 0.100 |
Why?
|
Genetic Diseases, Inborn | 1 | 2017 | 601 | 0.100 |
Why?
|
Pressure | 1 | 2015 | 1155 | 0.100 |
Why?
|
Marijuana Abuse | 1 | 2016 | 410 | 0.100 |
Why?
|
Risk Reduction Behavior | 1 | 2018 | 1098 | 0.100 |
Why?
|
Duodenum | 1 | 2014 | 485 | 0.100 |
Why?
|
Life Style | 2 | 2020 | 3886 | 0.090 |
Why?
|
Medicine | 1 | 2019 | 942 | 0.090 |
Why?
|
Boston | 3 | 2019 | 9304 | 0.090 |
Why?
|
Heart Failure | 1 | 2015 | 11593 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2015 | 1975 | 0.090 |
Why?
|
Wakefulness | 1 | 2018 | 1256 | 0.090 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2017 | 708 | 0.090 |
Why?
|
Colitis | 1 | 2019 | 1229 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2269 | 0.090 |
Why?
|
Menopause | 1 | 2018 | 1639 | 0.090 |
Why?
|
Recurrence | 1 | 2022 | 8426 | 0.090 |
Why?
|
Critical Care | 1 | 2022 | 2692 | 0.080 |
Why?
|
Brain | 5 | 2023 | 26947 | 0.080 |
Why?
|
Esophagoscopy | 1 | 2011 | 390 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2022 | 12951 | 0.080 |
Why?
|
Population Surveillance | 1 | 2020 | 2606 | 0.080 |
Why?
|
Cause of Death | 1 | 2020 | 3675 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2021 | 1933 | 0.080 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2019 | 6013 | 0.080 |
Why?
|
Cost-Benefit Analysis | 4 | 2023 | 5484 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2895 | 0.080 |
Why?
|
Pain | 2 | 2021 | 5065 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2019 | 2980 | 0.080 |
Why?
|
Women's Health | 1 | 2018 | 2057 | 0.080 |
Why?
|
Survival Rate | 2 | 2020 | 12721 | 0.080 |
Why?
|
Urodynamics | 2 | 2020 | 346 | 0.080 |
Why?
|
Recovery of Function | 1 | 2018 | 2970 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2021 | 3732 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3242 | 0.070 |
Why?
|
Administration, Oral | 1 | 2015 | 3991 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2021 | 5272 | 0.070 |
Why?
|
Self Report | 1 | 2018 | 3714 | 0.070 |
Why?
|
Conscious Sedation | 1 | 2011 | 529 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2019 | 4406 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15225 | 0.070 |
Why?
|
Pediatrics | 1 | 2021 | 3587 | 0.070 |
Why?
|
Regression Analysis | 1 | 2015 | 6354 | 0.070 |
Why?
|
Melanoma | 1 | 2024 | 5691 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2020 | 2420 | 0.060 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15399 | 0.060 |
Why?
|
Lymphocyte Subsets | 1 | 2005 | 310 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 7980 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7378 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5404 | 0.050 |
Why?
|
Sex Factors | 1 | 2017 | 10504 | 0.050 |
Why?
|
Deglutition | 1 | 2024 | 208 | 0.050 |
Why?
|
Antiemetics | 1 | 2024 | 187 | 0.050 |
Why?
|
Disease Progression | 2 | 2017 | 13468 | 0.050 |
Why?
|
Prognosis | 2 | 2020 | 29557 | 0.050 |
Why?
|
Interleukin-13 | 1 | 2024 | 372 | 0.050 |
Why?
|
Physicians | 1 | 2020 | 4580 | 0.050 |
Why?
|
Defecography | 1 | 2021 | 17 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16534 | 0.050 |
Why?
|
Psychomotor Agitation | 1 | 2023 | 304 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2021 | 26183 | 0.050 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2020 | 102 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12604 | 0.040 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2021 | 296 | 0.040 |
Why?
|
Pregnancy | 1 | 2022 | 29742 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15773 | 0.040 |
Why?
|
Age Factors | 1 | 2017 | 18358 | 0.040 |
Why?
|
Chicago | 1 | 2020 | 254 | 0.040 |
Why?
|
Parasitic Diseases | 1 | 2018 | 76 | 0.040 |
Why?
|
Esophagus | 1 | 2024 | 1023 | 0.040 |
Why?
|
Pelvic Organ Prolapse | 1 | 2020 | 119 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1097 | 0.040 |
Why?
|
Models, Organizational | 1 | 2020 | 546 | 0.040 |
Why?
|
Capsule Endoscopy | 1 | 2018 | 100 | 0.040 |
Why?
|
Child, Preschool | 2 | 2017 | 42062 | 0.040 |
Why?
|
Hyperplasia | 1 | 2020 | 1154 | 0.030 |
Why?
|
Models, Economic | 1 | 2021 | 715 | 0.030 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2023 | 867 | 0.030 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2020 | 357 | 0.030 |
Why?
|
Siblings | 1 | 2020 | 824 | 0.030 |
Why?
|
Canada | 1 | 2021 | 2111 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2005 | 2201 | 0.030 |
Why?
|
Acute Disease | 2 | 2023 | 7225 | 0.030 |
Why?
|
Prostaglandins | 1 | 2017 | 398 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2021 | 2504 | 0.030 |
Why?
|
Coffee | 1 | 2019 | 582 | 0.030 |
Why?
|
Cognition | 2 | 2023 | 6953 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1722 | 0.030 |
Why?
|
Fruit | 1 | 2020 | 1160 | 0.030 |
Why?
|
Antigens, CD | 1 | 2005 | 3997 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2020 | 821 | 0.030 |
Why?
|
Beverages | 1 | 2019 | 819 | 0.030 |
Why?
|
Eosinophilia | 1 | 2018 | 559 | 0.030 |
Why?
|
Drug Approval | 1 | 2021 | 808 | 0.030 |
Why?
|
Avoidance Learning | 1 | 2015 | 248 | 0.030 |
Why?
|
SEER Program | 1 | 2019 | 1530 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2019 | 970 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3298 | 0.030 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2020 | 932 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14490 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3812 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1659 | 0.030 |
Why?
|
Zenker Diverticulum | 1 | 2011 | 28 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3533 | 0.020 |
Why?
|
Health Behavior | 1 | 2023 | 2617 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1436 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2021 | 1996 | 0.020 |
Why?
|
Esophageal Achalasia | 1 | 2011 | 94 | 0.020 |
Why?
|
Animals | 1 | 2022 | 167768 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2023 | 3446 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2014 | 1197 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 22032 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3615 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3425 | 0.020 |
Why?
|
Health Policy | 1 | 2021 | 2677 | 0.020 |
Why?
|
Social Behavior | 1 | 2015 | 1131 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5862 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2886 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1878 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2015 | 1433 | 0.020 |
Why?
|
HIV-1 | 1 | 2005 | 6850 | 0.020 |
Why?
|
Perfusion | 1 | 2011 | 1374 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6234 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2018 | 2523 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2015 | 2414 | 0.020 |
Why?
|
DNA | 1 | 2019 | 7199 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14641 | 0.020 |
Why?
|
Tuberculosis | 1 | 2018 | 2001 | 0.020 |
Why?
|
Cost of Illness | 1 | 2015 | 1936 | 0.020 |
Why?
|
Water | 1 | 2011 | 1402 | 0.020 |
Why?
|
Genotype | 1 | 2019 | 12945 | 0.020 |
Why?
|
Clinical Competence | 1 | 2020 | 4775 | 0.020 |
Why?
|
Inflammation | 1 | 2024 | 10718 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2005 | 778 | 0.010 |
Why?
|
Sleep | 1 | 2018 | 4744 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7338 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6157 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2011 | 1647 | 0.010 |
Why?
|
HIV Infections | 1 | 2005 | 17275 | 0.010 |
Why?
|
Virus Replication | 1 | 2005 | 2430 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20500 | 0.010 |
Why?
|
Infant | 1 | 2016 | 36055 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2011 | 20055 | 0.010 |
Why?
|
Concepts
(343)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(100)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_